Serum N-glycan analysis in breast cancer patients - Relation to tumour biology and clinical outcome

Molecular Oncology

Volumn 10, Issue 1, 2016, Pages 59-72

  Haakensen, Vilde D ^a,b   Steinfeld, Israel ^c,d   Saldova, Radka ^e   Shehni, Akram Asadi ^e   Kifer, Ilona ^d   Naume, Bjørn ^a   Rudd, Pauline M ^e   Børresen Dale, Anne Lise ^a,b   Yakhini, Zohar ^c,d,f  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d AGILENT TECHNOLOGIES   (Israel)

^e NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING   (Ireland)

^f Agilent Laboratories Israel   (Israel)

Author keywords

Breast cancer; Gene expression; Integrated data analysis; mRNA; Serum N glycans

Indexed keywords

GLYCAN; INTEGRIN; N GLYCAN; UNCLASSIFIED DRUG; POLYSACCHARIDE; TUMOR MARKER;

ARTICLE; BIOLOGY; BREAST CANCER; CANCER PATIENT; CELL ADHESION; CELL SURVIVAL; DNA DAMAGE; FEMALE; FOCAL ADHESION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; METABOLISM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TUMOR CELL; BLOOD; BREAST TUMOR; COHORT ANALYSIS; GENETICS; PATHOLOGY; TREATMENT OUTCOME; TUMOR EMBOLISM;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOPLASTIC CELLS, CIRCULATING; POLYSACCHARIDES; TREATMENT OUTCOME;

EID: 84953359913     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2015.08.002     Document Type: Article

References (48)

1. Abd Hamid U.M., Royle L., Saldova R., Radcliffe C.M., Harvey D.J., Storr S.J., et al. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 2008, 18:1105-1118.
2. Aure M.R., Leivonen S.K., Fleischer T., Zhu Q., Overgaard J., Alsner J., et al. Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors. Genome Biol. 2013, 14:R126.
3. Aure M.R., Steinfeld I., Baumbusch L.O., Liestol K., Lipson D., Nyberg S., et al. Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data. PLoS One 2013, 8:e53014.
4. Bicker K.L., Sun J., Harrell M., Zhang Y., Pena M., Thompson P., et al. Synthetic lectin arrays for the detection and discrimination of cancer associated glycans and cell lines. Chem. Sci. 2012, 3:1147-1156.
5. Bosma A.J., Weigelt B., Lambrechts A.C., Verhagen O.J., Pruntel R., Hart A.A., et al. Detection of circulating breast tumor cells by differential expression of marker genes. Clin. Cancer Res. 2002, 8:1871-1877.
6. Chan D.S., Vieira A.R., Aune D., Bandera E.V., Greenwood D.C., McTiernan A., et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann. Oncol. 2014 Oct, 25(10):1901-1914.
7. Chandler K., Goldman R. Glycoprotein disease markers and single protein-omics. Mol. Cell Proteomics 2013, 12:836-845.
8. Cross S.S., Hamdy F.C., Deloulme J.C., Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005, 46:256-269.
9. Eaton S., Bartlett K., Pourfarzam M. Mammalian mitochondrial beta-oxidation. Biochem. J. 1996, 320(Pt 2):345-357.
10. Eden E., Lipson D., Yogev S., Yakhini Z. Discovering motifs in ranked lists of DNA sequences. PLoS Comput. Biol. 2007, 3:e39.
11. Enerly E., Steinfeld I., Kleivi K., Leivonen S.K., Aure M.R., Russnes H.G., et al. miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 2011, 6:e16915.
12. Hand D.J. Statistical methods in diagnosis. Stat. Methods Med. Res. 1992, 1:49-67.
13. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-7070.
14. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., et al. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
15. Julien S., Ivetic A., Grigoriadis A., QiZe D., Burford B., Sproviero D., et al. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Cancer Res. 2011, 71:7683-7693.
16. Kelder T., van Iersel M.P., Hanspers K., Kutmon M., Conklin B.R., Evelo C.T., et al. WikiPathways: building research communities on biological pathways. Nucleic Acids Res. 2012, 40:D1301-D1307.
17. Kim H., Golub G.H., Park H. Missing value estimation for DNA microarray gene expression data: local least squares imputation. Bioinformatics 2005, 21:187-198.
18. Koppenol W.H., Bounds P.L., Dang C.V. Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 2011, 11:325-337.
19. Kuster B., Wheeler S.F., Hunter A.P., Dwek R.A., Harvey D.J. Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. Anal. Biochem. 1997, 250:82-101.
20. Lebrilla C.B. Is high throughput glycomics possible?. Mass Spectrom. 2013, 2:S0016.
21. Lesniak D., Sabri S., Xu Y., Graham K., Bhatnagar P., Suresh M., et al. Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer. PLoS One 2013, 8:e71987.
22. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
23. Li C., Simeone D.M., Brenner D.E., Anderson M.A., Shedden K.A., Ruffin M.T., et al. Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J. Proteome. Res. 2009, 8:483-492.
24. Miwa H.E., Koba W.R., Fine E.J., Giricz O., Kenny P.A., Stanley P. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer. Glycobiology 2013, 23:1477-1490.
25. Molloy T.J., Bosma A.J., Baumbusch L.O., Synnestvedt M., Borgen E., Russnes H.G., et al. The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients. Breast Cancer Res. 2011, 13:R61.
26. Naume B., Borgen E., Kvalheim G., Karesen R., Qvist H., Sauer T., et al. Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Clin. Cancer Res. 2001, 7:4122-4129.
27. Naume B., Zhao X., Synnestvedt M., Borgen E., Russnes H.G., Lingjaerde O.C., et al. Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Mol. Oncol. 2007, 1:160-171.
28. Olsen A.H., Bihrmann K., Jensen M.B., Vejborg I., Lynge E. Breast density and outcome of mammography screening: a cohort study. Br. J. Cancer 2009, 100:1205-1208.
29. Parker N., Turk M.J., Westrick E., Lewis J.D., Low P.S., Leamon C.P. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal. Biochem. 2005, 338:284-293.
30. Pierce A., Saldova R., Abd Hamid U.M., Abrahams J.L., McDermott E.W., Evoy D., et al. Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients. Glycobiology 2010, 20:1283-1288.
31. Potapenko I.O., Haakensen V.D., Lüders T., Helland A., Bukholm I., Sørlie T., et al. Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression. Mol. Oncol. 2010 Apr, 4(2):98-118.
32. Potapenko I.O., Lüders T., Russnes H.G., Helland Å., Sørlie T., Kristensen V.N., et al. Glycan-related gene expression signatures in breast cancer subtypes; relation to survival. Mol. Oncol. 2015 Apr, 9(4):861-876.
33. Rinaldo P., Matern D., Bennett M.J. Fatty acid oxidation disorders. Annu. Rev. Physiol. 2002, 64:477-502.
34. Royle L., Campbell M.P., Radcliffe C.M., White D.M., Harvey D.J., Abrahams J.L., et al. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal. Biochem. 2008, 376:1-12.
35. Royle L., Radcliffe C.M., Dwek R.A., Rudd P.M. Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol. Biol. 2006, 347:125-143.
36. Ruhaak L.R., Miyamoto S., Lebrilla C.B. Developments in the identification of glycan biomarkers for the detection of cancer. Mol. Cell Proteomics 2013, 12:846-855.
37. Saldova R., Asadi Shehni A., Haakensen V.D., Steinfeld I., Hilliard M., Kifer I., et al. Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC. J. Proteome Res. 2014 May 2, 13(5):2314-2327.
38. Saldova R., Reuben J.M., Abd Hamid U.M., Rudd P.M., Cristofanilli M. Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts. Ann. Oncol. 2011, 22:1113-1119.
39. Smyth G.K. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions Using R and Bioconductor 2005, 397-420. Springer, New York.
40. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10869-10874.
41. Sorlie T., Wang Y., Xiao C., Johnsen H., Naume B., Samaha R.R., et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 2006, 7:127.
42. Steinfeld I., Navon R., Creech M., Yakhini Z., Tsalenko A. ENViz: A Cytoscape App for Integrated Statistical Analysis and Visualization of Sample-matched Data with Multiple Data Types 2014, http://apps.cytoscape.org/apps/enviz.
43. Steinfeld I., Navon R., Creech M.L., Yakhini Z., Tsalenko A. ENViz: a Cytoscape App for integrated statistical analysis and visualization of sample-matched data with multiple data types. Bioinformatics 2015 May 15, 31(10):1683-1685.
44. Ugorski M., Laskowska A. Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells. Acta Biochim. Pol. 2002, 49:303-311.
45. Weigelt B., Horlings H.M., Kreike B., Hayes M.M., Hauptmann M., Wessels L.F., et al. Refinement of breast cancer classification by molecular characterization of histological special types. J. Pathol. 2008, 216:141-150.
46. Wiedswang G., Borgen E., Karesen R., Kvalheim G., Nesland J.M., Qvist H., et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J. Clin. Oncol. 2003, 21:3469-3478.
47. Wiedswang G., Borgen E., Schirmer C., Karesen R., Kvalheim G., Nesland J.M., et al. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Int. J. Cancer 2006, 118:2013-2019.
48. Zhou Z., Zhou J., Du Y. Estrogen receptor alpha interacts with mitochondrial protein HADHB and affects beta-oxidation activity. Mol. Cell Proteomics 2012, 11:M111.